Analystreport

Stada Arzneimittel (OTCMKTS: STDAF) had its "sell" rating re-affirmed by analysts at DZ Bank AG.

STADA ARZNEIMI NAMEN  (STDAF) 
NASDAQ:AMEX Investor Relations: stada.com